Q/C Technologies, Inc. (QCLS)
NASDAQ: QCLS · Real-Time Price · USD
4.640
-0.060 (-1.28%)
At close: Sep 26, 2025, 4:00 PM EDT
4.430
-0.210 (-4.53%)
After-hours: Sep 26, 2025, 7:55 PM EDT
Q/C Technologies Employees
Q/C Technologies had 2 employees as of December 31, 2024. The number of employees decreased by 4 or -66.67% compared to the previous year.
Employees
2
Change (1Y)
-4
Growth (1Y)
-66.67%
Revenue / Employee
n/a
Profits / Employee
-$5,263,563
Market Cap
8.19M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 2 | -4 | -66.67% |
Dec 31, 2023 | 6 | -3 | -33.33% |
Dec 31, 2022 | 9 | 0 | - |
Dec 31, 2021 | 9 | 3 | 50.00% |
Dec 31, 2020 | 6 | - | - |
Related Stocks
Company Name | Employees |
---|---|
Amazon.com | 1,546,000 |
Berkshire Hathaway | 392,400 |
JPMorgan Chase & Co. | 317,233 |
Microsoft | 228,000 |
Alphabet | 187,103 |
Apple | 164,000 |
Tesla | 125,665 |
Taiwan Semiconductor Manufacturing Company | 83,825 |
QCLS News
- 2 days ago - Q/C Technologies (Formerly TNF Pharmaceuticals) Commences Trading on Nasdaq Under New Ticker Symbol “QCLS” - Business Wire
- 3 days ago - TNF Pharmaceuticals Announces Name Change to Q/C Technologies and New Ticker Symbol “QCLS” to Reflect Strategic Focus on Quantum Class Photonic Computing - Business Wire
- 10 days ago - TNF Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Requirement - Business Wire
- 19 days ago - TNF Pharmaceuticals to Present at the H.C. Wainwright 27th Annual Global Investment Conference - Business Wire
- 23 days ago - TNF Pharmaceuticals Announces Closing of $7 Million Private Placement - Business Wire
- 25 days ago - PharmaCyte Biotech, Inc. Increases Stake in TNF Pharmaceuticals Around Recent License for Breakthrough Light Speed Computing Platform for Use in Cryptocurrency Applications - Business Wire
- 25 days ago - TNF Pharmaceuticals Secures Exclusive Global Rights to Innovative Light Speed Computing Accelerator for Use in Cryptocurrency Applications - Business Wire
- 4 weeks ago - TNF Pharmaceuticals Announces Reverse Stock Split For Nasdaq Listing Compliance - Business Wire